A 10-month-old infant presented with suspected ACD after the topical use of timolol eyedrops (Timoptol 0.5%; Santen Italy, Milano, Italy) on an infantile haemangioma in the right mammary region ( Figure 1A).Initially, we had prescribed daily topical applications of timolol 0.5% eyedrops for 2 weeks. This had been followed by a 6-month course of oral propanolol, and then, after partial resolution of the infantile haemangioma, a prolongation with topical timolol 0.5% eyedrops recently followed. After 1 month, during this second period of topical treatment, the parents reported redness and itching on the area, so the application was discontinued. On clinical examination, some FIGURE 1 Clinical presentation of the patient. (A), Infantile hemangioma of the mammary region before starting any treatment. (B), Eczematous reaction and central crusts on the haemangioma itself and the area around it. (C), Resolution of the eczema after drug discontinuation and topical application of corticosteroids. (D), Positive patch test reaction to timolol 0.5% eyedrops. (E), Negative patch test result with benzalkonium chloride 0.1% aq SACCHELLI ET AL. 255